|
Journal description
All volumes of the corresponding journal
All issues of the corresponding volume
All articles of the corresponding issues
7 results found
| no | title | author | magazine | year | volume | issue | page(s) | type |
| 1 | Disclosures |
2001 |
23 | S1 |
p. A40- 1 p. |
article |
||
| 2 | Effects of washout and dose-escalation periods on theefficacy, safety, and tolerability of galantamine in patients previously treated with donepezil: ongoing clinical trials |
Rasmusen, Lee |
2001 |
23 | S1 |
p. A25-A30 nvt p. |
article |
|
| 3 | Overview |
Morris, John C. |
2001 |
23 | S1 |
p. A1-A2 nvt p. |
article |
|
| 4 | Panel discussion:recommendations for prescribers |
Morris, John C. |
2001 |
23 | S1 |
p. A31-A39 nvt p. |
article |
|
| 5 | Pharmacokinetic profiles of current therapiesfor Alzheimer's disease: implications for switching to galantamine |
Farlow, Martin R. |
2001 |
23 | S1 |
p. A13-A24 nvt p. |
article |
|
| 6 | Pharmacokinetic rationale for switching from donepezil to galantamine |
Maelicke, Alfred |
2001 |
23 | S1 |
p. A8-A12 nvt p. |
article |
|
| 7 | Switching previous therapies for Alzheimer's disease to galantamine |
Ferris, Steven H. |
2001 |
23 | S1 |
p. A3-A7 nvt p. |
article |
7 results found